Peiyuan Guben Tongluo Ointment for Elderly Sarcopenia

With the agarose concentrating group of Peiyuan Guben Tongluo Ointment set as the parallel control and an external control established simultaneously, this study aimed to evaluate the increases from baseline in DXA-measured limb muscle mass after 12 weeks of medication in elderly sarcopenia patients treated with the Ejiao concentrating group of Peiyuan Guben Tongluo Ointment.

NCT Number	NCT07538674
Lead Sponsor	Shanghai Yueyang Integrated Medicine Hospital Collaborators: Shanghai University of Traditional Chinese Medicine, DongE E Jiao Coporation Limited
Conditions	Sarcopenia in Elderly
Enrollment	60 participants
Start Date	2026-04
Primary Completion	2027-03-31 (estimated)
Study Completion	2028-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-04-20